Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet’s disease in the Shanghai Adamantiades-Behçet’s disease database: a prospective cohort study

Table 4 Factors associated with event-free survival of IBS

Risk factor	HR (95%CI)	P
Log Rank test risk factor
Male sex	0.57 (0.30–1.09)	0.09
Onset of BS < 7 years	2.25 (1.17–4.33)	0.015
WBC > 6.4, × 10⁹/L	1.77 (0.94–3.32)	0.077
Hb < 123, g/L	1.55 (0.83–2.92)	0.172
ESR > 24, mm/h	2.18 (1.11–4.28)	0.024
Biologics	0.369 (0.192–0.710)	0.003
IFX therapy^#	0.46 (0.22–0.95)	0.035
Poor compliance	3.26 (1.73–6.13)	0.000
Multiple Cox regression risk factor
Onset of BS < 7 years	2.43 (1.24–4.76)	0.010
ESR > 24, mm/h	1.97 (0.99–3.91)	0.053
Poor compliance	3.06 (1.61–5.80)	0.001

^#IFX therapy was administrated at 0, 2, and 6 weeks (intravenous), and then maintained with the same dosage of IFX every 8 weeks

ISSN: 1750-1172